Our findings suggest that the inhibition of RHCG and TRPA1 enhances the sensitivity of lung cancer cells to radiation and may provide a new target for the combination of radiotherapy and immunotherapy for lung cancer treatment. The gene discussed is RHCG; the disease is lung cancer.